Savara SVRA
NASDAQ SVRA
$4.81 -0.24 (-4.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Savara (SVRA) Change in Account Payables (2016 - 2017)

Updated

Savara (SVRA) reported Change in Account Payables of -$127,000 for Q1 2017, compared with -$776,000 a year earlier.

Analysis

Savara (SVRA) Change in Account Payables (2016 - 2017) Analysis & Trends

For FY2016, Savara posted Change in Account Payables of -$1.97 million.

  • By year, Change in Account Payables came in at $1.23 million in FY2015 (+203.0%) and $406,000 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -70.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 18.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Savara 987.97 Mn 987.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 -127,000.00
Mar 31, 2016 -776,000.00
API Access

Savara Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=SVRA&period=max&api_key=YOUR_API_KEY